Help Patients Overcome Hurdles With GLP-1 Agonists

February 2024

Rxs are rolling in for GLP-1 agonists...liraglutide (Victoza, etc), semaglutide (Ozempic, etc), dulaglutide (Trulicity), etc.

It’s partly because these injectable meds are a first-line option for type 2 diabetes in patients who also have certain medical conditions...such as heart or kidney disease.

But side effects or other problems often get in the way of therapy. Help navigate common hurdles with GLP-1 agonist Rxs.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Med Safety Prevent Problems With Meds That Can Catch Fire
Smoking Cessation Know How Zonnic Stacks Up for Smoking Cessation
Acetaminophen Revisit Acetaminophen Safety
Medication Errors Use Error Reports as a Tool to Enhance Safety
Epilepsy Watch for Cenobamate for Partial-Onset Seizures
Inhalers Learn About the Environmental Impact of Inhalers
Injectables Help Patients Overcome Hurdles With GLP-1 Agonists
NatMed Spotlight Answer Questions About Cocoa for Heart Health or Cognition

Help Patients Overcome Hurdles With GLP-1 Agonists

Practical advice for a better career, with unlimited access to CE

Table of Contents